Navigation Links
Fluoride Treatment of Synthetic Bio-material Assists Dental Bone Regeneration
Date:5/2/2013

Lawrence, KS (PRWEB) May 03, 2013

Journal of Oral Implantology – For a successful dental implant, a sufficient amount of jawbone is necessary. Deficient bone must be built up before the procedure. Guided bone regeneration is a common treatment, and bio-materials treated with fluoride are displaying cell proliferation that can improve this process.

The Journal of Oral Implantology reports on a study of bio-resorbable synthetic hydroxyapatite granules used as a bone supplement material. When these granules were exposed to a 4 percent sodium fluoride solution, cell proliferation was increased.

Bone regeneration techniques include the use of artificial materials such as hydroxyapatite and tricalcium phosphate. Implant products are being made with surface coatings or textures that have a biological effect on protein attachment and cell proliferation. When fluoride is added to this surface, it activates osteoblastic, or bone-making, cells and increases the rate of bone regeneration.

In this study, hydroxyapatite granules were treated with a neutral 4 percent sodium fluoride solution. This led to the formation of a reactant resembling calcium fluoride on the surface of the granules. Immediate but slow release of fluoride came from the granules, and the concentration increased over time. Migration of human osteoblast-like MG-63 cells was confirmed when compared to a nonfluoridated control sample.

Fluoride concentrations of 1.0-2.0 parts per million (ppm) showed this positive effect. When the concentration reached 5.0 ppm, however, the opposite effect was observed—the fluoride significantly inhibited cell proliferation.

The authors conclude that the fluoride solution stimulates bone regeneration. The slow release of fluoride from hydroxyapatite granules facilitates osteogenesis, making this a beneficial method to supply fluoride and promote cell proliferation.

Full text of the article, “Fluoride-Treated Bio-Resorbable Synthetic Hydroxyapatite Promotes Proliferation and Differentiation of Human Osteoblastic MG-63 Cells,” Journal of Oral Implantology, Vol. 39, No.1, 2013, is available at http://www.joionline.org/doi/full/10.1563/AAID-JOI-D-10-00175.

###

About Journal of Oral Implantology
The Journal of Oral Implantology is the official publication of the American Academy of Implant Dentistry and of the American Academy of Implant Prosthodontics. It is dedicated to providing valuable information to general dentists, oral surgeons, prosthodontists, periodontists, scientists, clinicians, laboratory owners and technicians, manufacturers, and educators. The JOI distinguishes itself as the first and oldest journal in the world devoted exclusively to implant dentistry. For more information about the journal or society, please visit: http://www.joionline.org

Media Contact:
Bridget Lamb
Allen Press, Inc.
800/627-0326 ext. 248
blamb(at)allenpress(dot)com

Read the full story at http://www.prweb.com/releases/2013/5/prweb10682953.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Removing Fluoride: What's the Fuss?
2. Zion Health’s Native Remedy-Natural Clay Toothpaste without Fluoride; Now Available at Marquette Food Co-op
3. Zion Health Announces Native Remedy-Natural Clay Toothpaste without Fluoride formulated to help Prevent Gum Disease. Now Available At Whole Foods Market in Lafayette, CA.
4. Jacksonville, FL Periodontist, Dr. Richard E. Aguila, Offers Laser Gum Disease Treatment
5. Girls With Autism May Need Different Treatments Than Boys
6. Large genomic study identifies endometrial cancer subtypes, treatment opportunities
7. Women's Excellence in Menopause Now Offering Treatment Options for Decreased Sex Drive near Rochester Hills, Michigan; Natural Therapy Available via Bioidentical Hormones
8. Gastric bypass findings could lead to diabetes treatment
9. Into Action Drug Treatment Center Supports the March of Dimes Walk
10. Alzheimer's Treatment Clinical Trial Receives Clearance
11. Atlantic Spine Center Announces Updated Web Content on Spinal Stenosis New Treatments and a Better Approach to Spinal Stenosis Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/30/2016)... ... 30, 2016 , ... Shaolin Institute officially starts the annual ... intensive summer training camp starts on June 17th on Shaolin Institute Atlanta Campus. ... a fun and unique experience with an opportunity to learn KungFu martial arts ...
(Date:5/28/2016)... (PRWEB) , ... May 28, 2016 , ... SuperCloset is ... all too well the day to day issues, struggles and obstacles veterans’ need to ... Helping Veterans Grow Project provides active or retired military veteran(s) with a donated SuperCloset ...
(Date:5/27/2016)... ... May 27, 2016 , ... More than a third of American adults ... that bariatric surgery has received increased attention in recent years, as an article ... comes to weight loss, most people are familiar with the basic requirements of maintaining ...
(Date:5/27/2016)... ... 2016 , ... With over 60 percent of acute stroke survivors being left ... to aid in the rehabilitation process has steadily increased. Ekso Bionics had been working ... due to stroke. , Ekso Bionics has now received clearance from the U.S. Food ...
(Date:5/27/2016)... York, NY (PRWEB) , ... May 27, 2016 ... ... care world, this installment is bolstered by inspiring human interest stories, courtesy of ... the developing trends and tech within the industry, from leading advocates and associations—namely ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... 27, 2016 According to the ... is driving ambulatory blood pressure monitoring system market growth. ... their ability to respond to different pressure rates, leading ... lead to various cardiovascular disorders such as heart failure, ... diseases are growing in prevalence each year. WHO estimates ...
(Date:5/26/2016)... ALBANY, New York , May 26, 2016 ... Transparency Market Research "Medical Waste Management Market - U.S. Industry ... the medical waste management market in the U.S. was valued ... expand at a CAGR of 3.4% from 2015 to 2023 ... report provides exhaustive analysis of current and emerging needle free ...
(Date:5/25/2016)... May 25,2016 FDA 510(k) ... Cellvizio platform for urological and surgical applications ... inventor of Cellvizio®, the multidisciplinary confocal laser endomicroscopy ... in the US with the 12 th ... Administration (FDA). This new FDA clearance covers Confocal ...
Breaking Medicine Technology: